메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

'김갑성' 기자의 전체기사

/C O R R E C T I O N -- CooperVision, Inc./

In the news release, CooperVision Expands MyDay® MiSight® 1 day Myopia Control Soft Contact Lenses Into Asia Pacific Region, issued 02-Mar-2026 by CooperVision, Inc. over PR Newswire, we are advised by the company that changes have been made. The complete, corrected release follows, with additional details at the end: CooperVision Expands MyDay® MiSight® 1 day Myopia Control Soft Contact Lenses Into Asia Pacific Region Second Phase of Rollout Builds on Strong Momentum Across Europe and UK. ROCHESTER, N.Y., March 2, 2026 -- CooperVision is continuing its
- 김갑성 기자
- 2026-03-03 10:27
The largest pharma show in Asia makes its return to Shangh…

SHANGHAI, March 3, 2026 -- CPHI & PMEC China 2026 is set to take place from 16 to 18 June 2026 at the Shanghai New International Expo Centre (SNIEC), building on its extremely successful run over the last few years. As the world's premier destination for pharmaceutical ingredients and manufacturing solutions, this year's edition is set to bring together over 110,000 attendees, and more than 3,600 local and international exhibitors. This comfortably makes CPHI & PMEC China Asia's largest pharma event, offering unparalleled opportunities to source, supply and innovate within Chin
- 김갑성 기자
- 2026-03-03 10:15
Royalty Pharma Appoints Kenneth Sun as Senior Vice Presid…

NEW YORK, March 3, 2026 -- Royalty Pharma plc (Nasdaq: RPRX) announced the appointment of Kenneth Sun as Senior Vice President and Head of Asia, effective May 2026. Ken will be based in Hong Kong and lead the company's royalty business in Asia. Ken joins Royalty Pharma from Morgan Stanley, where he was Head of Asia Pacific Healthcare Investment Banking. Asia-based biotechnology companies are now prolific creators of innovative therapeutics. In 2025, the out-licensing of Chinese medicines alone comprised over $130 billion of announced transaction value, up from approximately $14 billion
- 김갑성 기자
- 2026-03-03 10:15
Bright Eye Clinic Achieves Government Accreditation Amid Kore…

SEOUL, South Korea, March 3, 2026 -- Bright Eye Clinic announced its official accreditation under the Korean Accreditation Program for Hospitals Serving Foreign Patients (KAHF), administered by the Korea Health Industry Development Institute (KHIDI) under the Ministry of Health and Welfare. The accreditation is valid from April 25, 2025 to April 24, 2029, making Bright Eye Clinic the only ophthalmology clinic in Seoul with this certification. South Korea's medical tourism sector continues to expand, with 1.17 million foreign patients in 2024, the first time annual volumes excee
- 김갑성 기자
- 2026-03-03 10:00
AsiaMedic Delivers Improved FY2025 Performance as Core Imag…

[ 메디채널 김갑성 기자 ] Financial performance strengthened alongside business expansion as newly added capacity are ramped up during the year Profit attributable to owners of the Company doubled to S$2.0 million in FY2025 Disposal of 60% interest in aesthetic business sharpens focus on core healthcare operations SINGAPORE, March 3, 2026 -- SGX Catalist-listed AsiaMedic Limited ("AsiaMedic" or the "Company", and together with its subsidiaries, the "Group") today announced its financial results for the financial year ended 31 December ("FY2025"), r
- 김갑성 기자
- 2026-03-03 09:40
Efor strengthens its presence in Asia with the acquisition o…

LYON, France, March 3, 2026 -- Efor, a global leader specializing in quality and compliance for the Life Sciences industry, announces the acquisition of Singapore-based No deviation, a company recognized for its expertise in Commissioning, Qualification & Validation (CQV), Computer System Validation (CSV), Quality Compliance and Digital Enablement. Founded in 2013, Efor has built a leading international platform dedicated to quality and compliance for Life Sciences industries. With more than 3,000 professionals operating across 18 countries, the group supports global pharm
- 김갑성 기자
- 2026-03-03 09:00
US BioTek Laboratories Completes Merger With NutriPATH Patho…

SEATTLE and MELBOURNE, Australia, March 3, 2026 -- US BioTek Laboratories, a leading functional laboratory specializing in advanced immunological and integrative diagnostics, today announced the completion of its merger with NutriPATH Pathology, a respected functional pathology laboratory serving integrative and functional medicine practitioners. The merger marks a significant milestone for the global functional laboratory industry. It brings together the two organizations' specialized expertise and a shared commitment to clinical relevance, scientific rigor, and practitioner s
- 김갑성 기자
- 2026-03-03 02:15
Skyhawk Announces Australia's Therapeutic Goods Admini…

[ 메디채널 김갑성 기자 ] Australia's Therapeutic Goods Administration (TGA), responsible for approval of the safety, quality, and efficacy of therapeutic goods, has determined that Skyhawk's SKY-0515 orally-administered small molecule therapy for the treatment of Huntington's disease meets TGA eligibility criteria for registration via the provisional approval pathway. Skyhawk delivered its application for provisional approval to the TGA today. More than 115 patients are now on trial with SKY-0515. BOSTON, March 3, 2026 -- Skyhawk Therapeutics, Inc., a clinical-stage biotechnolog
- 김갑성 기자
- 2026-03-03 01:20
Innovaccer Receives Frost & Sullivan's 2026 United States New…

[ 메디채널 김갑성 기자 ] The recognition highlights Innovaccer's innovation leadership in transforming patient access through omnichannel, AI-powered engagement and workflow unification. SAN ANTONIO, March 3, 2026 -- Frost & Sullivan is pleased to announce that Innovaccer has received the 2026 United States New Product Innovation Recognition in the United States Patient Access Solutions Industry for its outstanding achievements in innovation, strategy execution, and customer impact. This recognition highlights Innovaccer's consistent leadership in modernizing patient access through AI-dri
- 김갑성 기자
- 2026-03-03 00:57
The Sigourney Award-2026 Now Accepting Applications for Ps…

International Prize Honors Trailblazing Work Advancing Psychoanalytic Thought and Principles — Cash Award and Global Recognition SAN FRANCISCO, March 2, 2026 -- The Sigourney Award Trust welcomes applications for The Sigourney Award-2026 from individuals, teams, and organizations worldwide whose work has advanced psychoanalytic thinking and principles. Applications are open through July 31, 2026, for work completed between 2016 and 2025. The Trust was established in 1989 by psychotherapist and community activist Mary Sigourney with a clear vision: to encourage bold, orig
- 김갑성 기자
- 2026-03-02 22:49

이전

1 2 3 4 5 6 7 8 9 10

많이 본 기사

최근기사

2026-03-03_TUE

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2026년 03월 03일 13시 00분